Takeda Sued By Ex-Employee For Innovation That Led To Vitamin Line
This article was originally published in PharmAsia News
Executive Summary
Takeda Pharmaceuticals is being sued by a 73-year-old former researcher for nearly $541,000, saying the $433 the firm paid him for his role in developing a vitamin B1 derivative was not enough. The man's discovery of an efficient way to obtain a key substance from the B1 vitamin derivative, fursultiamine, led to Takeda's highly successful line of Alinamin products. Takeda reported nearly $6 billion in sales from the Alinamin product line. The man received an additional $162 after 1998 and the firm's new program of compensation for on-the-job inventions. Takeda said it has fulfilled its obligations to the researcher. (Click here for more - a subscription may be required